Protein Phosphatase 2A Promotes CD8⁺ T Cell Effector Function through the Augmentation of CD28 Costimulation

Area of Science:

• Immunology
• Cell Biology
• Biochemistry

Background:

• Protein phosphatase 2A (PP2A) is a key regulator of cellular processes.
• Previous studies highlighted PP2A's role in CD4+ T cells and thymocyte development.
• The function of PP2A in CD8+ T cells remained largely unknown.

Purpose of the Study:

• To investigate the role of PP2A catalytic subunit α (Cα) in CD8+ T cell effector functions.
• To elucidate the impact of PP2A Cα deficiency on immune responses in vitro and in vivo.
• To understand the molecular mechanisms underlying PP2A's influence on T cell activation.

Main Methods:

• Genetic ablation of PP2A Cα subunit in CD8+ T cells.
• In vitro stimulation assays to assess proliferation and cytokine production.
• In vivo studies using viral infection and tumor models.
• Analysis of signaling pathways, including AKT phosphorylation.

Main Results:

• PP2A Cα deficiency in CD8+ T cells led to reduced proliferation and cytokine production.
• Mice lacking PP2A Cα in T cells showed impaired antiviral immunity and attenuated anti-tumor activity.
• Reduced infiltration of PP2A Cα-deficient CD8+ T cells into tumors was observed.
• PP2A Cα deficiency impaired CD28-induced AKT phosphorylation, hindering T cell costimulation.

Conclusions:

• PP2A is essential for promoting CD8+ T cell effector functions.
• PP2A Cα deficiency compromises both adaptive immunity and anti-tumor responses.
• PP2A acts as a critical regulator of CD28-mediated costimulation signaling in CD8+ T cells.